Le Lézard
Classified in: Science and technology
Subjects: Conference, Event, Product/Service

Enable Shapes the Future of Rebate Management with the Release of its New Product Feature and AI Reporting Capabilities at Catalyze 2024


Enable, the rebate management platform, at its annual conference, Catalyze, announced the launch of AI-Powered analytics for rebate management, along with its new Settlements solution. These additions expand the platform's comprehensive support by ensuring manufacturers, distributors, and retailers have full control over their rebate programs from negotiation to claim and settlement process. They also enhance the platform's analytics power, giving more controlled reporting and dashboards to rebate strategists and providing data analyst answers from natural language questions.

"We're committed to responding to the needs of the market and evolving our platform to make it even more valuable," said Andrew Butt, Founder & CEO of Enable. "We're giving everyone the ability to make better business decisions with our new AI reporting capabilities. With the new AI reporting add-on, users can access their data in a more natural way, allowing them to unlock the next best decision for their companies and rebate programs. The new Settlement feature allows manufacturers to manage the entire lifecycles of their rebate programs without ever having to leave the Enable platform. They will be able to negotiate, manage, and settle all in one place."

Enable has amped up its reporting capabilities by creating AI-powered analytics with natural language processing within the platform. Users of Enable's rebate management platform can ask questions in basic business language and get the results a trained business analyst would produce. The AI-powered analytics add-on also allows users to tailor their data to specific needs, like building real-time reports, analyze changes, outliers, trends, and correlations, creating customer dashboards, and much more.

Last year at Catalyze 2023, Enable announced Claims, which allows distributors and retailers to manage the entire lifecycle of a rebate program from start to finish. Settlement is the counterpart to Claims, enhancing the platform's end-to-end management capabilities for manufacturers and other suppliers by automating the process of crediting trading partners with their earned rebates. This reduces manual efforts such as time spent compiling and issuing credits and minimizes disputes due to misaligned earning calculations. The release also continues Enable's commitment to increased transparency and collaboration.

"Every year, we're building out our rebate management platform to ensure our customers have what they need to turn rebates from a perceived cost into an opportunity," said Butt. "This means building out cutting-edge AI reporting tools that allow rebate strategists to use natural language questions to generate data-analyst answers. Users will have even greater control over reports and dashboards that drive decision making. Plus, we're ensuring manufacturers have complete control over the whole rebate process, from negotiation to settlement."

For additional information, visit enable.com.

ABOUT ENABLE

Enable helps manufacturers, distributors, and retailers take control of their rebate programs and turn them into an engine for growth. Starting with finance and commercial teams, Enable helps companies to better manage rebate complexity with automated real-time data and insights, accurate forecasting, and stronger cross-functional alignment. This lets companies ? and everyone in their business ? know exactly where they are with rebates. Then they can extend Enable externally to suppliers and customers, setting them up with one collaborative place to author, agree, execute, and track the progress of their trading relationships.


These press releases may also interest you

at 17:20
The Phase IIa COURSE trial was a proof-of-concept study in people with moderate to very severe chronic obstructive pulmonary disease (COPD) with a broad range of blood eosinophil counts (BEC) and irrespective of emphysema, chronic bronchitis or...

at 14:15
Endeavor BioMedicines, a clinical-stage biotechnology company developing medicines with the potential to deliver transformational clinical benefits to patients with life-threatening diseases, announced results from a completed Phase 2a clinical trial...

at 12:20
Savara Inc. (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, presented a poster at the American Thoracic Society (ATS) 2024 International Conference that is taking place May 17-22, 2024, in San Diego,...

at 11:10
Orion Health, a global leader in digital health solutions, announced today that it has been awarded partner status by Panda Health for its Orchestral Health Intelligence Platform, one of three pillars of the Unified Healthcare Platform. Panda Health...

at 06:13
eWTP Arabia Capital Technology Fund I ("Techology Fund I"), managed by eWTP Arabia Capital ("eWTPA"), one of the leading private equity firms in the Middle East, was listed in the Preqin League Tables as the the fifth top-performing VC funds in the...

18 mai 2024
Celltrion partners with TV star Mollie Pearce to launch the second installation of the Where's Crohn's & Colitis (CC)? campaign for this year's World IBD Day (19 May 2024). The campaign focuses on access to IBD care and treatment as the burden of...



News published on and distributed by: